B26-0606

Vaccine Administration Protection Amendment Act of 2026

Introduced·2/25/26
Tion Text

Provides immunity from liability for vaccine administrators in the District of Columbia.

The Vaccine Administration Protection Amendment Act of 2026 grants immunity from liability for individuals authorized to administer vaccines in the District of Columbia. This immunity applies to certain claims related to the prescribing, dispensing, ordering, furnishing, or administering of vaccines. The immunity is contingent upon the vaccine being authorized by District law, following official guidance from the Centers for Disease Control and Protection or the Department of Health, or being recommended by a recognized medical or public health organization designated by the Director of the.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
In committee
Next
Committee decision

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

History

Mar 6

Council

Notice of Intent to Act on B26-0606 Published in the DC Register

Mar 3

Council

Referred to Committee on Health

Feb 25

Council

Introduced in Office of the Secretary